Australia markets close in 44 minutes

China SXT Pharmaceuticals, Inc. (SXTC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.0200-0.0400 (-3.77%)
At close: 04:00PM EDT
1.0500 +0.03 (+2.94%)
After hours: 07:57PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 588.15k
Enterprise value -7.73M
Trailing P/E 12.51
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.28
Price/book (mrq)0.12
Enterprise value/revenue -4.54
Enterprise value/EBITDA 0.57

Trading information

Stock price history

Beta (5Y monthly) 1.03
52-week change 3-79.60%
S&P500 52-week change 323.57%
52-week high 39.3750
52-week low 30.9400
50-day moving average 31.6170
200-day moving average 32.5125

Share statistics

Avg vol (3-month) 31.14M
Avg vol (10-day) 3519.19k
Shares outstanding 5565.53k
Implied shares outstanding 6579k
Float 8589.6k
% held by insiders 122.01%
% held by institutions 11.62%
Shares short (15 Apr 2024) 463.63k
Short ratio (15 Apr 2024) 40.18
Short % of float (15 Apr 2024) 414.89%
Short % of shares outstanding (15 Apr 2024) 411.25%
Shares short (prior month 15 Mar 2024) 45.54k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:25
Last split date 305 Oct 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Mar 2023
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-995.02%

Management effectiveness

Return on assets (ttm)-45.75%
Return on equity (ttm)-141.60%

Income statement

Revenue (ttm)1.7M
Revenue per share (ttm)3.65
Quarterly revenue growth (yoy)-22.20%
Gross profit (ttm)N/A
EBITDA -13.21M
Net income avi to common (ttm)-14.14M
Diluted EPS (ttm)-26.9600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)11.47M
Total cash per share (mrq)15.75
Total debt (mrq)3.57M
Total debt/equity (mrq)70.37%
Current ratio (mrq)1.47
Book value per share (mrq)6.97

Cash flow statement

Operating cash flow (ttm)-111.2k
Levered free cash flow (ttm)-400.4k